Clinical trial
LUMIER² Study : LUpus Molecular Immunomonitoring to Evaluate the Risk of Relapse
NCT02811094 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LUMIER² Study : LUpus Molecular Immunomonitoring to Evaluate the Risk of Relapse
- Lead sponsor
- Assistance Publique Hopitaux De Marseille
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- November 9, 2016
- Completion date
- December 12, 2020
- Enrollment
- 210 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
systemic lupus erythematosus (sle)